Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (18381)	1/29/1999 8:58:00 PM
From: DaiS	Read Replies (1) \| Respond to of 23519

>>The delay IMO is waiting for the 6 week study period in the UK that the NHS has started.>> MK, There has to be some explanation for delay in EU but I am not convinced by this explanation. The health systems vary widely in different EU countries. Viagra is approved why not muse? If UK decides to approve ED treatments on NHS ad libitum...or UK decides to be highly restrictive what difference does this make to muse approval in other EU countries? Of course if NHS is restrictive, French might tell us to %$£$ off and do the opposite. On another point, all the communications that I have had from Astra suggest that is is the responsibility of Astra to seek approval not Vivus. Why should Astra hurry too much? OK they might upset Vivus a bit, otherwise they should choose best time for launches, evidently no hurry at the moment. DaiS

To: Mkilloran who wrote (18381)	1/29/1999 9:35:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

martin, I have to disagree with your reasons for the European delays. What does England's NHS have to do with policy in France and Germany? They have already decided NOT to pay for Viagra. I assume that MUSE will be covered by their national health plans because there really is no abuse potential like Viagra. Every elderly male has some form of erectile dysfunction in the sense that their ability to achieve and maintain an erection is not as good as it was when they were younger. Deterioration of sexual function is no different than what happens to other bodily functions (eg hearing, vision, joint mobility) as we age. For this reason, any elderly man can go to his doctor claiming to have ED and technically he is not lying. But what he is really suffering from is aging and not ED. It would be interesting to know exactly why some of these important European countries have not granted MUSE individual licensing within the standard 30 days. It it because Vivus was depending on Astra to do the required paper work and Astra has been slow because of its Zeneca merger? Perhaps it is because Vivus itself was slow in filing the required paper work? Now THAT would explain everything!